Literature DB >> 16729014

Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas.

Manohar Pradhan1, Vera M Abeler, Håvard E Danielsen, Claes G Tropé, Björn Ake Risberg.   

Abstract

Image cytometric DNA ploidy analysis of endometrial carcinomas was performed to determine whether ploidy status and ploidy-related parameters like DNA index, percentage of cells exceeding 5c and 9c, correlate with histologic subtype. This is a prospective study of 391 patients with stage I endometrial carcinoma which included 331 (85%) endometrioid adenocarcinoma, 22 (6%) serous adenocarcinoma, 7 (2%) clear cell adenocarcinoma, 2 (0.5%) small cell carcinoma, 1 (0.3%) undifferentiated carcinoma, and 28 (7%) unclassifiable adenocarcinoma. Twenty-five percent of endometrioid adenocarcinomas were non-diploid. In contrast, all clear cell adenocarcinomas and 21/22 (95%) of serous adenocarcinomas were non-diploid. Hyperdiploidy (25 cases) was found only in endometrioid adenocarcinomas. Mean DNA index of the stemline in serous adenocarcinoma (1.72) and clear cell adenocarcinoma (1.81) was higher than in endometrioid adenocarcinoma (1.1). The difference in ploidy-related parameters between endometrioid adenocarcinoma and serous adenocarcinoma was highly significant (P<0.001). In addition, Grade 3 endometrioid adenocarcinoma showed significant difference in all ploidy-related parameters compared with grade 1 and grade 2 tumors (P<0.001). Our results show that DNA ploidy-related parameters may be valuable in subtyping histologically difficult cases of endometrial carcinomas. Published online 26 May 2006.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16729014     DOI: 10.1038/modpathol.3800641

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  20 in total

1.  Genomic imbalances in endometrial adenocarcinomas - comparison of DNA ploidy, karyotyping and comparative genomic hybridization.

Authors:  Wanja Kildal; Francesca Micci; Bjørn Risberg; Vera M Abeler; Gunnar B Kristensen; Sverre Heim; Håvard E Danielsen
Journal:  Mol Oncol       Date:  2011-10-20       Impact factor: 6.603

2.  Automated assessment of DNA ploidy, chromatin organization, and stroma fraction to predict prognosis and adjuvant therapy response in patients with stage II colorectal carcinoma.

Authors:  Zhixun Zhao; Xiaochen Zhang; Zhongwu Li; Yibo Gao; Xu Guan; Zheng Jiang; Zheng Liu; Ming Yang; Haipeng Chen; Xiaolong Ma; Runkun Yang; Zhao Lu; Hengchang Liu; Lujing Yang; Aiwen Wu; Shuangmei Zou; Xishan Wang
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

Review 3.  Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.

Authors:  Jonathan D Black; Diana P English; Dana M Roque; Alessandro D Santin
Journal:  Womens Health (Lond)       Date:  2014-01

Review 4.  Application of DNA methylation biomarkers for endometrial cancer management.

Authors:  Shi-Wen Jiang; Jinping Li; Karl Podratz; Sean Dowdy
Journal:  Expert Rev Mol Diagn       Date:  2008-09       Impact factor: 5.225

5.  The genomics and genetics of endometrial cancer.

Authors:  Andrea J O'Hara; Daphne W Bell
Journal:  Adv Genomics Genet       Date:  2012-03

Review 6.  Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era.

Authors:  Håvard E Danielsen; Manohar Pradhan; Marco Novelli
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

7.  DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium.

Authors:  Manohar Pradhan; Ben Davidson; Vera Maria Abeler; Håvard Emil Danielsen; Claes Göran Tropé; Gunnar Balle Kristensen; Björn Åke Risberg
Journal:  Virchows Arch       Date:  2012-07-24       Impact factor: 4.064

8.  Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis.

Authors:  E A Akbay; C G Peña; D Ruder; J A Michel; Y Nakada; S Pathak; A S Multani; S Chang; D H Castrillon
Journal:  Oncogene       Date:  2012-06-11       Impact factor: 9.867

9.  Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A.

Authors:  Jessica C Price; Lana M Pollock; Meghan L Rudd; Sarah K Fogoros; Hassan Mohamed; Christin L Hanigan; Matthieu Le Gallo; Suiyuan Zhang; Pedro Cruz; Praveen F Cherukuri; Nancy F Hansen; Kirk J McManus; Andrew K Godwin; Dennis C Sgroi; James C Mullikin; Maria J Merino; Philip Hieter; Daphne W Bell
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

10.  DNA content, Cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus.

Authors:  Evelyn Neppelberg; Anne Christine Johannessen
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-05-25       Impact factor: 3.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.